Countries declined to receive nearly 35 million AstraZeneca doses, opting to replace them with vaccines manufactured by Johnson & Johnson, Pfizer and Moderna, a document said.

For the six months, poorer nations asked for only around half a million doses of the AstraZeneca Covishield vaccine produced by the Serum Institute of India, which Covax had initially regarded as its main supplier.